The Global Genetic Testing Services Market was valued at USD 34.23 Billion in 2023 and is projected to reach USD 49.99 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period (2023-2032). This expansion is driven by increasing awareness of genetic disorders, advancements in genomic technologies, and growing adoption of precision medicine approaches across global healthcare systems.
As genetic testing becomes integral to modern medical practice, service providers are playing a pivotal role in disease prevention, diagnosis, and personalized treatment strategies. This report profiles the Top 10 Companies in the Genetic Testing Services Industry—leading laboratories, diagnostic networks, and genomic innovators shaping the future of medical testing.
🔟 1. LabCorp (Laboratory Corporation of America)
Headquarters: Burlington, North Carolina, USA
Key Offering: Comprehensive clinical genetic testing
LabCorp operates one of the largest diagnostic laboratory networks worldwide, providing over 5,000 genetic tests including oncology panels, pharmacogenomics, and rare disease diagnostics. Their extensive menu includes carrier screening, prenatal testing, and hereditary cancer risk assessment.
Technology Leadership:
- Whole exome and genome sequencing capabilities
- AI-powered variant interpretation platforms
- Integrated health data analytics
Download FREE Sample Report: Genetic Testing Services Market – View in Detailed Research Report
9️⃣ 2. Quest Diagnostics
Headquarters: Secaucus, New Jersey, USA
Key Offering: Diagnostic genetic testing services
Quest Diagnostics processes over 25 million clinical lab tests annually, including an expanding menu of molecular and genetic tests. The company has made significant investments in women’s health, oncology, and neurological testing capabilities.
Technology Leadership:
- BluePrint ovarian cancer genomic profiling
- QCDx liquid biopsy technology
- Automated reporting systems
8️⃣ 3. Genomic Health (Exact Sciences)
Headquarters: Redwood City, California, USA
Key Offering: Oncotype DX cancer genomic tests
Now part of Exact Sciences, Genomic Health specializes in genomic tests that analyze tumor biology to guide cancer treatment decisions, with particular expertise in breast, prostate, and colorectal cancers.
Technology Leadership:
- Oncotype DX Breast Recurrence Score test
- AR-V7 Nucleus Detect assay
- Multi-cancer early detection research
7️⃣ 4. NeoGenomics Laboratories
Headquarters: Fort Myers, Florida, USA
Key Offering: Comprehensive cancer genomics
NeoGenomics provides advanced genetic testing for hematologic malignancies and solid tumors through its network of CAP-accredited laboratories, serving over 3,000 hospitals and oncology practices.
Technology Leadership:
- NeoTYPE cancer profiling panels
- Minimal Residual Disease monitoring
- Global expansion initiatives
Download FREE Sample Report: Genetic Testing Services Market – View in Detailed Research Report
6️⃣ 5. Eurofins Scientific
Headquarters: Luxembourg
Key Offering: Specialized genomic testing
Eurofins operates a global network of laboratories offering over 200,000 analytical methods, with strong capabilities in clinical genomics, forensic DNA analysis, and pharmaceutical genomics.
Technology Leadership:
- Whole genome sequencing services
- Non-invasive prenatal testing
- Pathogen genomic surveillance
5️⃣ 6. Ambry Genetics (Konica Minolta)
Headquarters: Aliso Viejo, California, USA
Key Offering: Clinical exome and genome sequencing
Ambry Genetics has pioneered several first-in-class genetic tests, with comprehensive menus for hereditary cancer, cardiology, neurology, and other specialty areas.
Technology Leadership:
- +RNAinsight combined transcriptome analysis
- Ambry Genetics Health Screen
- Disease-specific panel expansions
4️⃣ 7. Roche Diagnostics
Headquarters: Basel, Switzerland
Key Offering: Integrated genomic workflows
Roche provides end-to-end solutions from sample preparation to data interpretation, with particular strength in oncology and inherited disease testing platforms.
Technology Leadership:
- AVENIO liquid biopsy portfolio
- Foundation Medicine partnership
- Automated sequencing solutions
3️⃣ 8. Illumina
Headquarters: San Diego, California, USA
Key Offering: Sequencing-based testing services
The leading sequencing technology provider has expanded into clinical testing through its clinical genomics division and acquisitions like Grail for multi-cancer early detection.
Technology Leadership:
- NovaSeq X sequencing systems
- TruSight informatics solutions
- Population genomics programs
2️⃣ 9. Centogene
Headquarters: Rostock, Germany
Key Offering: Rare disease diagnostics
Centogene has built the world’s most comprehensive rare disease data repository, offering multi-omic diagnostic services for over 7,000 genetic conditions.
Technology Leadership:
- CentoCloud data analytics platform
- Newborn and pediatric testing focus
- Global rare disease collaborations
1️⃣ 10. 23andMe
Headquarters: Sunnyvale, California, USA
Key Offering: Consumer genomic testing
23andMe has brought genetic testing to millions of consumers through ancestry and health predisposition services, while accumulating valuable genomic datasets for research.
Technology Leadership:
- FDA-approved health reports
- Therapeutics pipeline development
- Research participant network
Get Full Report Here: Genetic Testing Services Market – View in Detailed Research Report
🧬 Outlook: The Evolving Landscape of Genetic Testing
The genetic testing market is undergoing rapid transformation as single-gene tests give way to comprehensive genomic profiling and population-scale screening applications.
📈 Key Market Trends:
- Expansion of non-invasive prenatal testing to additional conditions
- Growing clinical adoption of whole genome sequencing
- Integration of genetic testing into standard care pathways
- Development of polygenic risk scores for common diseases
- Increasing regulatory oversight and quality standardization
Market Segmentation Insights
By Test Type:
- Prenatal Testing – 28% market share, focused on chromosomal abnormalities
- Newborn Screening – Expanding to 50+ conditions in developed markets
- Predictive Testing – Growing demand for cancer risk assessment
- Pharmacogenomics – Fastest-growing segment at 8.1% CAGR
By End User:
- Hospital Labs – Developing in-house genomic capabilities
- Reference Labs – Handling complex and esoteric testing
- Specialty Clinics – Increasing integration with genetic counseling
Get Full Report Here: Genetic Testing Services Market – View in Detailed Research Report
The companies profiled above are not just performing genetic tests—they’re driving the precision medicine revolution through technological innovation and clinical implementation.